Medtronic Plc (MDT)

111.42
NYSE
Prev Close 111.84
Day Low/High 111.15 / 112.48
52 Wk Low/High 72.13 / 122.15
Exchange NYSE
Shares Outstanding 1344.41B
Market Cap 150.36B
P/E Ratio 33.18
Div & Yield N.A. (N.A)

Latest News

7 High-Tech Winners in Medical Diagnostics and Devices

7 High-Tech Winners in Medical Diagnostics and Devices

These names combine healthcare research with state-of-the art technology.

Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?

Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?

Monday's market action was in no way similar to that recent disparity between the 'haves' and 'have nots.'

Real Money Post Industrial Average Outperforms, Despite Outbreak

Real Money Post Industrial Average Outperforms, Despite Outbreak

The RMPIA rebounded more than 22% in the June quarter to finish up 7.8% at the 2020 half mark.

The Fed Has Our Backs, Trading Thoughts, 'Facebook Shops'

The Fed Has Our Backs, Trading Thoughts, 'Facebook Shops'

As State economies begin the slow process of reopening, the Fed is there to support market function. Facebook's latest e-commerce foray has investors cheering.

Medtronic Stock Is in 'No Man's Land'

Medtronic Stock Is in 'No Man's Land'

The medical device company is scheduled to report earnings this week.

Fibocall: Technical Trading Texts

Medtronic Presents an Opportunity, and Not Just Because It Makes Ventilators

Medtronic Presents an Opportunity, and Not Just Because It Makes Ventilators

The charts of the producer of medical equipment are holding up well, though its shares eventually could run into resistance.

Real Money Post Industrial Average Holds Own Amid Covid-19 Selloff

Real Money Post Industrial Average Holds Own Amid Covid-19 Selloff

Amid a flood of corporate warnings over the coronavirus, all the major stock market indexes finished last month down 6.4% to 10.1%.

Jim Cramer: Rate Cut No Cure for Coronavirus

Jim Cramer: Rate Cut No Cure for Coronavirus

But don't throw up your arms yet -- here are names that could be golden opportunities.

Three Strategies for Income Investors

Three Strategies for Income Investors

For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.

Does the Macro Matter for Equities? Salesforce Dreamforce Begins, Trading Apple

Does the Macro Matter for Equities? Salesforce Dreamforce Begins, Trading Apple

Tuesday's Dreamforce features a discussion between Salesforce's Marc Benioff and Apple's Tim Cook.

Medtronic Set to Trade Higher Unless Earnings Derail the Rally

Medtronic Set to Trade Higher Unless Earnings Derail the Rally

Let's see what the charts have to say.

Medtronic Operating Toward Renewed Gains

Medtronic Operating Toward Renewed Gains

After correction, the medical device maker could see longer-term gains to the $150-$161 area.

7 Medical Products Stocks With the Right Prescription for Gains

7 Medical Products Stocks With the Right Prescription for Gains

Top picks in the fast-growing medical products market.

Medtronic Hits Our Price Target: Time to Take Profits?

Medtronic Hits Our Price Target: Time to Take Profits?

A follow-up to our story in June.

Profit Taking, Rate Cuts and a Play on Zscaler: Market Recon

Profit Taking, Rate Cuts and a Play on Zscaler: Market Recon

Evaluating the market and policy discussion ahead of Jackson Hole, and how I am playing Zscaler on this weakness.

Real Money Post-Industrial Average Leads Major Indexes So Far for Year

Real Money Post-Industrial Average Leads Major Indexes So Far for Year

In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.

Dexcom Looks Like It Can Finally Break Out on the Topside

Dexcom Looks Like It Can Finally Break Out on the Topside

Let's check the charts and indicators on the glucose-monitoring company.

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.

Medtronic Is Edging Closer to an Upside Breakout on the Charts

Medtronic Is Edging Closer to an Upside Breakout on the Charts

No one knows their business as well as the CEO.

Trade War Heats Up, Fundamental Analysis, Boeing on the Hot Seat: Market Recon

Trade War Heats Up, Fundamental Analysis, Boeing on the Hot Seat: Market Recon

China's President Xi has obviously found surrender distasteful.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

A Technical Strategy for Tandem Diabetes Care

A Technical Strategy for Tandem Diabetes Care

Are we late to the game with the stock up so much?

Real Money Post-Industrial Average Shines in January, Outperforming S&P 500

Real Money Post-Industrial Average Shines in January, Outperforming S&P 500

RMPIA soared 9.9% for the month, led by 11 double-digit gainers.

Medtronic Stock Is Showing Promise on the Daily Chart

Medtronic Stock Is Showing Promise on the Daily Chart

Here's how to trade MDT, going long.

Medtronic Upgraded to Buy at BTIG Research

8 Top Year-End Trading Ideas for Bargain Hunters

8 Top Year-End Trading Ideas for Bargain Hunters

These eight S&P 500 stocks have some of the worst returns year-to-date and represent a diverse roster of promising bounce candidates.

Medtronic Is Testing the 200-Day Average and I Am Not Too Optimistic

Medtronic Is Testing the 200-Day Average and I Am Not Too Optimistic

Prices are testing the October and November lows and also testing the rising 200-day moving average line.